Topiramate Tablets

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA, University of Minnesota

Conditions

HealthyObesity, Childhood

Early Phase 1

Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP

CompletedNCT04986631

University of MinnesotaObesity, Childhood

Start: 2022-04-04End: 2024-09-26Updated: 2026-08-24

Phase 1

Topiramate 25 mg Tablets Under Fasting Conditions

CompletedNCT00905606

Teva Pharmaceuticals USAHealthy

Start: 2001-06-30End: 2001-06-30Updated: 2024-08-19